(IN BRIEF) EQT Life Sciences has exited its investment in Tubulis following Gilead Sciences’ agreement to acquire the German biotechnology company in a deal valued at up to $5 billion including milestones. EQT supported Tubulis’ development into a clinical-stage oncology … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Sweden, Technology
Tagged ADC platform, antibody-drug conjugates, biotechnology acquisition, Cancer Therapies, Christoph Broja, clinical-stage biotech, Dominik Schumacher, EQT Life Sciences, EQT Life Sciences Realizes Investment Success with Sale of Tubulis to Gilead Sciences, EQT Life Sciences Supports Growth of Tubulis Leading to Major Acquisition by Gilead Sciences, Gilead Sciences, Munich biotech, oncology investment, pharmaceutical industry, Tubulis
(IN BRIEF) EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, led through the LSP Dementia … Read the full press release
Posted in Healthcare, Investment, Pharma & Biotech, Sweden
Tagged agitation, Alzheimer’s disease, Andera Partners, dementia care, Deraphan, EQT Life Sciences, Exciva, Exciva Raises €51 Million Series B to Support Phase 2 Trial for Alzheimer’s Agitation Treatment, Fountain Healthcare Partners, Gimv, Juliette Lee, LBBW, LifeArc, LSP Dementia Fund, neuropsychiatric symptoms, neuroscience therapeutics, Phase 2 clinical trial, Philip Scheltens, Series B financing
(IN BRIEF) EQT Life Sciences has exited its investment in Vivasure Medical following the sale of the Irish medical technology company to Haemonetics. Backed by EQT since 2016, Vivasure developed the PerQseal® Elite system, a bioabsorbable, sutureless solution for large-bore … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Ireland, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged Anne Portwich, endovascular interventions, EQT Life Sciences, EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics, Galway Ireland, Haemonetics, healthcare investment, life sciences, LSP Health Economics Fund, medical technology, PerQseal Elite, structural heart procedures, vessel closure systems, Vivasure Medical
(IN BRIEF) EQT Life Sciences has invested in U.S.-based Kinaset Therapeutics as part of a USD 103 million oversubscribed Series B financing. The funding will support the clinical advancement of frevecitinib, a novel inhaled pan-JAK inhibitor designed to treat a … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged asthma treatment, biopharmaceuticals, clinical-stage biotech, Daniela Begolo, EQT Life Sciences, EQT Life Sciences Backs Kinaset Therapeutics in USD 103m Series B Financing, Forge Life Science Partners, frevecitinib, inhaled therapeutics, Kinaset Therapeutics, pan-JAK inhibitor, RA Capital Management, respiratory diseases, Series B financing
(IN BRIEF) EIB is providing up to €37.5 million in venture debt to Xeltis as part of a new €50 million financing package that will help bring aXess, the company’s regenerative vascular access conduit, to market. The investment follows excellent … Read the full press release
Posted in Banks, Energy, Gas & Oil, European Union, Financial, Healthcare, Infrastructure & Utilities, Investment, Luxembourg, Netherlands, News, Pharma & Biotech
Tagged Alexander Goemans, aXess, commercialization funding, EIB, Eliane Schutte, end stage renal disease, Endogenous Tissue Restoration, EQT Life Sciences, ETR platform, EU pivotal trial, European Investment Bank, hemodialysis, Invest-NL, InvestEU, LSP Health Economics Fund 2, MedTech innovation, PFAS free polymer technology, regenerative implants, Robert de Groot, US pivotal trial, vascular access conduit, venture-debt financing, Xabg, Xeltis, Xeltis Advances Regenerative Implant Portfolio with Strong Backing from EIB and Existing Investors
(IN BRIEF) Cyted Health has raised USD 44 million in Series B financing led by EQT Life Sciences with participation from Advent Life Sciences, the British Business Bank, Morningside, BGF, and HCA Healthcare. The funds will accelerate Cyted’s commercial rollout … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Science, Sweden, Technology, United Kingdom
Tagged Advent Life Sciences, BGF, biomarker testing, British Business Bank, Bruno Holthof, Cyted Health, EndoSign, EQT Life Sciences, esophageal cancer, gastroenterology, gastrointestinal diagnostics, HCA Healthcare, Marcel Gehrung, Morningside, NHS, oncology, partnership, Series B funding, sustainability, University of Cambridge, US expansion
(IN BRIEF) EQT Life Sciences has led a Series A investment in Mosanna Therapeutics to advance its lead drug candidate, MOS118—a nasal spray designed to treat obstructive sleep apnea—into Phase 2 trials. Co-investors include Pivotal bioVenture Partners, Forbion, Norwest, and … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Sweden, Switzerland, Technology
Tagged airway reflex restoration, Basel, biotech funding, Daniela Begolo, David Weber, EQT Life Sciences, Forbion, Forty51 Ventures, HTGF, MOS118, Mosanna Therapeutics, nasal spray therapy, neurological treatment, non-invasive sleep apnea therapy, Norwest, obstructive sleep apnea, OSA treatment, partnership, Phase 2 clinical trial, Pivotal bioVenture Partners, Redwood City, Supermoon Capital, sustainability
(IN BRIEF) Nua Surgical, an Irish medical device company, has raised €6.5 million in a Series A funding round led by EQT Life Sciences, with participation from Kidron Capital, Texas Medical Center Venture Fund, Enterprise Ireland, and other investors. The … Read the full press release
Posted in Financial, Healthcare, Investment, Ireland, Sweden
Tagged C-section surgeries, Enterprise Ireland, EQT Life Sciences, healthcare systems, Ireland, Kidron Capital, maternal health innovation, Nua Surgical, patient safety, regulatory approval, series A funding, surgical access, team expansion, Texas Medical Center Venture Fund
(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release
Posted in Business, Denmark, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Cardior Pharmaceuticals, Christoph Broja, Claudia Ulbrich, Denmark, EQT, EQT Life Sciences, Germany, Heart Diseases, Novo Nordisk, partnership, Professor Thomas Thum, RNA Therapies, sustainability
(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for a total deal value of $1.05 billion. This acquisition underscores Amolyt’s significant advancements in developing novel treatments for rare endocrine … Read the full press release
Posted in Business, Environment, European Union, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Alexion, Amolyt Pharma, AstraZeneca Rare Diseases, Eneboparatide, EQT Life Sciences, Felice Verduyn-van Weegen, Healthcare, hypoparathyroidism, partnership, sustainability, Thierry Abribat
(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences and Nextech Invest Ltd, with participation from new and existing investors including Frazier Life Sciences and Deep Track Capital. The … Read the full press release
Posted in Business, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged ADC Pipeline, cancer treatment, Christoph Broja, Deep Track Capital, Dominik Schumacher, EQT Life Sciences, Frazier Life Sciences, John de Koning, Kanishka Pothula, Nextech Invest Ltd, partnership, sustainability, TUB-030, TUB-040, Tubulis
(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology, United Kingdom
Tagged Drew Burdon, EQT, EQT Life Sciences, investment, Mark Wyatt, Michael Sjöström, partnership, Phagenesis, Phagenyx, Reinhard Krickl, sustainability, Swallowing Disorder Treatment
(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release
(PRESSEMITTEILUNG) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, eine zweckorientierte globale Investmentorganisation, hat die Gründung eines neu gegründeten Unternehmens bekannt gegeben Geschäftsbereich innerhalb seines Private Capital-Geschäftssegments mit dem Namen EQT Life Sciences. Die Gründung des neuen Unternehmens folgt auf den Abschluss … Read the full press release
Posted in Business, Healthcare, Investment, Science, Sweden, Technology
Tagged Akquisition, EQT, EQT AB, EQT Life Sciences, EQT Private Capital, LSP, Per Franzén, René Kuijten
(PRESS RELEASE) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced the establishment of a newly formed business line within its Private Capital business segment called EQT Life Sciences. The formation of the new entity follows … Read the full press release
Posted in Business, Healthcare, Investment, News, Science, Sweden, Technology
Tagged acquisition, EQT, EQT AB, EQT Life Sciences, EQT Private Capital, LSP, Per Franzén, René Kuijten
LSP will strengthen EQT’s position as one of the leading and most active private markets investors in the healthcare sector. LSP’s highly experienced team will complement EQT’s existing knowledge base within life sciences and expand EQT’s ability to support companies … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?